The MDC Mission

The Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC) carries out basic biomedical research with the aim of understanding the molecular basis of health and disease, and translating these findings as quickly as possible into clinical application. The research involves the diagnosis and treatment of diseases, as well as their prevention.

Research Highlights


Personalized medicine: T cells fight cancer

A very promising approach in fighting cancer is targeting mutations of cancer cells. Scientists at the MDC now can explain which mutations are suitable for therapy and why cell culture tests are sometimes not enough.



Blood vessels sprout under pressure

It is blood pressure that drives the opening of small capillaries during angiogenesis. A team of researchers led by Prof. Holger Gerhardt of the MDC observed the process for the first time and published their findings in Nature Cell Biology.



Construction of BIMSB building

MDC celebrates construction of new BIMSB building in the heart of Berlin

On 25 May 2016, guests and employees of the MDC and the BIMSB celebrated the start and the progress of construction on the future BIMSB building on Humboldt-Universität’s Campus Nord in Berlin-Mitte.


Gaetano Gargiulo

Finding chinks in the molecular armor of glioblastoma

Researcher Gaetano Gargiulo will build his new research group at the  MDC. With the help of Helmholtz funding, he wants to find new ways of combating deadly brain tumors.



Yin and Yang in the Body

The EU-LIFE Scientific Workshop took place on May 12 and 13 in Vienna. One of the topics: the effects of new therapeutic strategies against cancer can be the opposite of those that are intended.